Profile data is unavailable for this security.
About the company
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
- Revenue in USD (TTM)21.17bn
- Net income in USD1.07bn
- Incorporated2000
- Employees64.82k
- LocationKoninklijke Philips NVHigh Tech Campus 5EINDHOVEN 5656 AENetherlandsNLD
- Phone+31 205977777
- Websitehttps://www.philips.com/
More ▼
Mergers & acquisitions
| Acquired company | PHIA:AEX since announced | Transaction value |
|---|---|---|
| SpectraWAVE Inc | 17.19% | -- |
Data delayed at least 15 minutes, as of Feb 12 2026 16:35 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cooper Companies Inc | 4.09bn | 374.90m | 16.28bn | 15.00k | 44.32 | 1.97 | 21.63 | 3.98 | 1.87 | 1.87 | 20.46 | 42.06 | 0.3312 | 1.71 | 5.29 | 272,826.70 | 3.03 | 8.04 | 3.32 | 8.86 | 65.54 | 66.01 | 9.16 | 24.66 | 1.13 | 6.32 | 0.2332 | 0.2049 | 5.06 | 10.98 | -4.44 | 9.48 | 3.15 | -- |
| Hologic Inc | 4.13bn | 543.80m | 16.76bn | 7.07k | 31.16 | 3.19 | 19.97 | 4.06 | 2.41 | 2.41 | 18.28 | 23.51 | 0.4608 | 2.57 | 6.79 | 583,663.40 | 6.07 | 11.22 | 6.82 | 12.85 | 56.51 | 60.20 | 13.18 | 21.99 | 3.32 | 15.76 | 0.3246 | 0.00 | 1.74 | 1.66 | -28.35 | -12.69 | -0.5168 | -- |
| Insulet Corp | 2.52bn | 246.20m | 17.65bn | 3.90k | 72.78 | 12.75 | 52.88 | 7.00 | 3.45 | 3.45 | 34.85 | 19.68 | 0.833 | 1.62 | 6.02 | 646,641.00 | 8.13 | 6.00 | 10.05 | 7.03 | 71.46 | 67.05 | 9.76 | 9.22 | 2.18 | 27.39 | 0.423 | 0.00 | 22.07 | 22.92 | 102.76 | 104.84 | -4.75 | -- |
| West Pharmaceutical Services Inc | 3.02bn | 491.70m | 17.71bn | 10.60k | 36.47 | 5.80 | 27.49 | 5.87 | 6.75 | 6.75 | 41.41 | 42.44 | 0.7757 | 4.63 | 5.13 | 284,707.60 | 12.32 | 15.61 | 14.46 | 18.70 | 35.58 | 38.00 | 15.88 | 18.84 | 2.18 | -- | 0.0638 | 10.20 | -1.92 | 9.48 | -16.97 | 15.31 | 24.43 | 5.84 |
| Illumina Inc | 4.34bn | 850.00m | 17.78bn | 8.97k | 21.30 | 6.53 | 24.70 | 4.09 | 5.46 | 5.46 | 27.84 | 17.82 | 0.6709 | 2.61 | 5.41 | -- | 13.13 | -10.15 | 17.32 | -12.15 | 66.61 | 65.39 | 19.57 | -23.18 | 1.72 | -- | 0.4221 | -- | -0.6633 | 6.04 | 169.50 | 5.32 | -- | -- |
| Zimmer Biomet Holdings Inc | 8.23bn | 705.00m | 18.95bn | 17.00k | 26.96 | 1.49 | 10.53 | 2.30 | 3.55 | 3.55 | 41.42 | 64.11 | 0.3703 | 1.10 | 5.17 | -- | 3.17 | 3.03 | 3.58 | 3.46 | 69.71 | 71.01 | 8.56 | 9.10 | 1.10 | 4.74 | 0.3718 | 29.10 | 7.20 | 6.08 | -21.98 | -- | 9.26 | 0.00 |
| Steris PLC | 5.83bn | 708.66m | 23.88bn | 17.79k | 33.88 | 3.34 | 19.95 | 4.10 | 7.19 | 7.18 | 59.09 | 72.93 | 0.5658 | 4.92 | 6.12 | 327,662.40 | 6.91 | 5.04 | 7.59 | 5.51 | 44.11 | 43.75 | 12.21 | 10.69 | 1.75 | 20.99 | 0.2094 | 37.51 | 6.24 | 12.49 | 10.64 | 8.40 | 11.52 | 8.99 |
| DexCom Inc | 4.52bn | 720.70m | 26.58bn | 10.30k | 38.53 | 9.75 | 27.54 | 5.89 | 1.77 | 1.77 | 11.08 | 6.99 | 0.6519 | 3.02 | 4.28 | 438,436.90 | 10.40 | 8.79 | 16.41 | 11.75 | 60.20 | 64.97 | 15.96 | 14.90 | 1.38 | -- | 0.4785 | 0.00 | 11.34 | 22.27 | 6.41 | 41.63 | 14.79 | -- |
| Veeva Systems Inc | 3.08bn | 860.33m | 29.10bn | 7.29k | 34.44 | 4.13 | 32.34 | 9.45 | 5.14 | 5.14 | 18.41 | 42.84 | 0.4234 | -- | 9.15 | 422,472.40 | 11.83 | 11.33 | 13.50 | 14.35 | 75.67 | 72.60 | 27.93 | 23.96 | -- | -- | 0.00 | 0.00 | 16.20 | 19.99 | 35.84 | 18.85 | 36.56 | -- |
| Koninklijke Philips NV (ADR) | 21.17bn | 1.07bn | 30.52bn | 64.82k | 28.83 | 2.35 | 12.70 | 1.44 | 1.11 | 1.11 | 22.14 | 13.67 | 0.6378 | 3.22 | 4.95 | 326,595.80 | 3.22 | -0.9494 | 4.48 | -1.30 | 45.18 | 44.19 | 5.05 | -1.57 | 0.9405 | 8.09 | 0.4239 | -- | -1.04 | 0.5947 | 206.52 | -1.93 | -5.68 | -1.62 |
| Waters Corp | 3.17bn | 642.63m | 32.29bn | 7.60k | 30.58 | 12.61 | 38.02 | 10.20 | 10.77 | 10.77 | 53.03 | 26.11 | 0.6569 | 2.46 | 4.05 | -- | 13.34 | 17.03 | 14.53 | 20.68 | 59.28 | 59.01 | 20.30 | 22.40 | -- | 16.77 | 0.3546 | -- | 6.99 | 6.00 | 0.7518 | 4.26 | -8.14 | -- |
| GE HealthCare Technologies Inc | 20.63bn | 2.09bn | 36.10bn | 54.00k | 17.40 | 3.48 | 13.21 | 1.75 | 4.55 | 4.55 | 45.03 | 22.77 | 0.5893 | 5.93 | 4.31 | 381,944.40 | 6.15 | 6.70 | 8.46 | 9.25 | 39.98 | 40.44 | 10.44 | 10.49 | 1.13 | 9.97 | 0.4866 | 1.85 | 4.84 | 3.74 | 4.57 | 0.7558 | 13.23 | -- |
| Agilent Technologies Inc | 6.95bn | 1.30bn | 36.46bn | 18.10k | 28.24 | 5.41 | 22.92 | 5.25 | 4.56 | 4.56 | 24.34 | 23.82 | 0.5655 | 3.29 | 4.94 | 383,867.40 | 10.61 | 11.44 | 12.82 | 13.67 | 52.73 | 53.25 | 18.75 | 18.82 | 1.52 | 18.30 | 0.3322 | 20.76 | 6.73 | 5.41 | 1.09 | 12.63 | 27.88 | 7.10 |
| Resmed Inc | 5.40bn | 1.49bn | 37.82bn | 10.60k | 25.66 | 5.98 | 22.37 | 7.01 | 10.12 | 10.12 | 36.75 | 43.39 | 0.6901 | 2.34 | 5.53 | 509,256.50 | 19.00 | 15.33 | 21.94 | 17.76 | 60.85 | 57.29 | 27.53 | 21.96 | 2.32 | -- | 0.095 | 28.94 | 9.84 | 11.72 | 37.20 | 17.64 | -1.02 | 1.69 |
Data as of Feb 12 2026. Currency figures normalised to Koninklijke Philips NV's reporting currency: US Dollar USD
3.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Mondrian Investment Partners Ltd.as of 30 Sep 2025 | 7.91m | 0.82% |
| Fiduciary Management, Inc.as of 30 Sep 2025 | 7.18m | 0.75% |
| Dimensional Fund Advisors LPas of 30 Sep 2025 | 4.22m | 0.44% |
| Strategic Advisers LLCas of 30 Sep 2025 | 2.55m | 0.26% |
| Causeway Capital Management LLCas of 30 Sep 2025 | 1.96m | 0.20% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2025 | 1.92m | 0.20% |
| Parametric Portfolio Associates LLCas of 30 Sep 2025 | 1.83m | 0.19% |
| Brandes Investment Partners LPas of 30 Sep 2025 | 1.62m | 0.17% |
| Envestnet Asset Management, Inc.as of 30 Sep 2025 | 1.30m | 0.14% |
| Aperio Group LLCas of 30 Sep 2025 | 1.29m | 0.13% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
